Loading...
Loading...
Jim Cramer said on
CNBC's Mad Money that
Microsoft CorporationMSFT is going to post an excellent quarter next week. He regrets that he didn't buy it when it dipped below $50.
Gilead Sciences, Inc.GILD is too cheap to sell, thinks Cramer.
Cramer believes that fundamentals in
TG Therapeutics IncTGTX are not represented by it current price movement.
He thinks that it is a speculative stock and investors are now looking elsewhere, because there are so many cheap stocks like
Celgene CorporationCELG and
Gilead Sciences, Inc..
He likes
New York Community Bancorp, Inc.NYCB.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in